RUO supplier
Peptide Pros
Official site and public COA documents reviewed
Supplier documentation profile
- Supplier type
- Direct RUO catalog
- Documentation
- Public COA PDFs for 17 products, most from MZ Biolabs (Tucson, AZ)
- RUO language
- The site disclaimer states products are not to be injected, not intended for bodybuilding or tanning, and not for use as food additives, drugs, cosmetics, or household chemicals. Purchasers must be 18 or older.
- Testing claims
- The supplier claims USA-based third-party lab COA reports. A reviewed BPC-157 COA from MZ Biolabs shows HPLC purity, mass spectrometry identity confirmation, lot number, and analysis date. The FAQ guarantees above 99% purity on all products.
Observable documentation fields
35/100 public-record coverage
This measures fields in normalized public records. It does not score product quality, sterility, legal compliance, or suitability.
Editorial record
The COA Reports page lists 17 unique downloadable COA PDFs covering peptides (BPC-157, CJC-1295, Ipamorelin, Melanotan 2, Sermorelin, Tirzepatide, Semaglutide) and non-peptide compounds (GW-501516, MK-677, Clenbuterol, Letrozole, Exemestane, Tamoxifen, Raloxifene, Toremifene, Sildenafil, Vardenafil). A reviewed BPC-157 COA PDF names MZ Biolabs (Tucson, AZ) as the testing lab, with Ken Pendarvis, ChE listed as analytical chemist; the report includes lot number, analysis date, HPLC purity (100.0%), mass spectrometry confirmation, and expected vs measured mass. The page meta description states 'USA based third party lab COA reports.' The FAQ states products are manufactured in the U.S.A. and ship from Colorado, with a 99% purity guarantee. The catalog also includes SARMs and liquid research chemicals. The disclaimer page states products are not for injection, bodybuilding, or tanning, and not for use as food additives, drugs, or cosmetics, with an 18+ age requirement. The site does not use the phrase 'research use only' in its main disclaimer; the wording is framed as prohibited uses instead.
Profile ownership: unclaimed. Company representatives will be able to propose identity and catalog updates without changing editorial or regulatory records.